IP Library › Granted Patent US 8,575,216
Granted Patent B2
US 8,575,216 · App. 12/849,926 · Granted Nov 5, 2013

Method of treatment for acute myelogenous leukemia

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,575,216
App. No.
12/849,926
Granted
Nov 5, 2013
Kind
B2
Abstract

This invention relates to a method of treating acute myelogenous leukemia with TPA along with Dexamethasone and choline magnesium trisalicylate.

Claims (1)

1. A method of treating a patient suffering from acute myelogenous leukemia which comprises administering to the patient an effective amount of 12-O-tetradecanoylphorbol-13-acetate (TPA) along with dexamethasone and choline magnesium trisalicylate.

Assignments (2)
NUNC PRO TUNC ASSIGNMENT Recorded Sep 5, 2013
From: THE UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY
To: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
Reel/Frame 031170/0331 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 24, 2011
From: STRAIR, ROGER
To: UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY
Reel/Frame 025685/0272 →